These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1818055)

  • 1. Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processor.
    Dobbs NA; Twelves CJ
    J Chromatogr; 1991 Dec; 572(1-2):211-7. PubMed ID: 1818055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection.
    Dine T; Brunet C; Luyckx M; Cazin M; Gosselin P; Cazin JL
    Biomed Chromatogr; 1990 Jan; 4(1):20-3. PubMed ID: 2310837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC.
    Dodde WI; Maring JG; Hendriks G; Wachters FM; Groen HJ; de Vries EG; Uges DR
    Ther Drug Monit; 2003 Aug; 25(4):433-40. PubMed ID: 12883225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved method for the determination of 4'-epidoxorubicin and seven metabolites in plasma by high-performance liquid chromatography.
    Maessen PA; Mross KB; Pinedo HM; van der Vijgh WJ
    J Chromatogr; 1987 Jul; 417(2):339-46. PubMed ID: 3477566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography.
    Nicholls G; Clark BJ; Brown JE
    J Pharm Biomed Anal; 1992; 10(10-12):949-57. PubMed ID: 1298402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully automated determination of a new anthracycline N-l-leucyldoxorubicin and six metabolites in plasma by high-performance liquid chromatography with on-line sample handling.
    de Jong J; Munniksma CN; Guérand WS; Bast A; van der Vijgh WJ
    J Chromatogr; 1992 Feb; 574(2):273-81. PubMed ID: 1618960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive and specific determination of the new anthracycline analog 4'-epidoxorubicin and its metabolites by high pressure liquid chromatography.
    Deesen PE; Leyland-Jones B
    Drug Metab Dispos; 1984; 12(1):9-13. PubMed ID: 6141919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection.
    Ricciarello R; Pichini S; Pacifici R; Altieri I; Pellegrini M; Fattorossi A; Zuccaro P
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):219-25. PubMed ID: 9613953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy.
    Barker IK; Crawford SM; Fell AF
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):323-9. PubMed ID: 8811443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
    Fogli S; Danesi R; Innocenti F; Di Paolo A; Bocci G; Barbara C; Del Tacca M
    Ther Drug Monit; 1999 Jun; 21(3):367-75. PubMed ID: 10365655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.
    Beijnen JH; Meenhorst PL; van Gijn R; Fromme M; Rosing H; Underberg WJ
    J Pharm Biomed Anal; 1991; 9(10-12):995-1002. PubMed ID: 1822225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring.
    Treder N; Maliszewska O; Olędzka I; Kowalski P; Miękus N; Bączek T; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Plenis A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121910. PubMed ID: 31830661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of doxorubicin, 4'-epidoxorubicin, and their metabolites by liquid chromatography.
    Weenen H; Osterop AP; van der Poort SE; Lankelma J; van der Vijgh WJ; Pinedo HM
    J Pharm Sci; 1986 Dec; 75(12):1201-4. PubMed ID: 3470504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive and simple high-performance liquid chromatographic method for the determination of doxorubicin and its metabolites in plasma.
    Andersen A; Warren DJ; Slørdal L
    Ther Drug Monit; 1993 Oct; 15(5):455-61. PubMed ID: 8249054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative metabolism and pharmacokinetics of doxorubicin and 4'-epidoxorubicin in plasma, heart and tumor of tumor-bearing mice.
    van der Vijgh WJ; Maessen PA; Pinedo HM
    Cancer Chemother Pharmacol; 1990; 26(1):9-12. PubMed ID: 2322993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue.
    Mürdter TE; Sperker B; Bosslet K; Fritz P; Kroemer HK
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):289-95. PubMed ID: 9657226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 4'-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detection.
    Moro E; Jannuzzo MG; Ranghieri M; Stegnjaich S; Valzelli G
    J Chromatogr; 1982 Jun; 230(1):207-11. PubMed ID: 6955311
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
    de Bruijn P; Verweij J; Loos WJ; Kolker HJ; Planting AS; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Jan; 266(2):216-21. PubMed ID: 9888978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE.
    Sottani C; Poggi G; Melchiorre F; Montagna B; Minoia C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():71-8. PubMed ID: 23337906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioanalysis of some anthracyclines in human plasma by capillary electrophoresis with laser-induced fluorescence detection.
    Reinhoud NJ; Tjaden UR; Irth H; van der Greef J
    J Chromatogr; 1992 Feb; 574(2):327-34. PubMed ID: 1618967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.